Safety of Medications During Breastfeeding
All four medications—cefixime 200 mg twice daily, phenylephrine, chlorpheniramine, and dextromethorphan—can be used during breastfeeding, though each requires specific considerations for infant monitoring.
Individual Medication Assessment
Cefixime (Antibiotic)
- Short courses of antibiotics are compatible with breastfeeding 1
- The FDA label states it is not known whether cefixime is excreted in human milk, but consideration should be given to temporarily discontinuing nursing during treatment 2
- However, guideline evidence from the Association of Anaesthetists (2020) clearly states that short courses of antibiotics commonly used peri-operatively show no evidence of harmful effects in breastfeeding women 1
- Related cephalosporins (cefuroxime) have been studied and found safe during lactation with only minor, self-limiting adverse effects in infants 3
Recommendation: Cefixime can be used during breastfeeding. Monitor the infant for gastrointestinal symptoms (diarrhea, loose stools) and potential candidiasis, which are the most common side effects in infants exposed to cephalosporins.
Phenylephrine (Decongestant)
- Due to poor oral bioavailability of 38%, phenylephrine is not likely to produce clinical effects in a breastfed infant 1
- The low systemic absorption means minimal transfer to breast milk
Recommendation: Phenylephrine is safe during breastfeeding due to its poor oral bioavailability limiting infant exposure.
Chlorpheniramine (Antihistamine)
- While not specifically mentioned in the provided guidelines, chlorpheniramine is a first-generation antihistamine
- The guideline discusses similar antihistamines: cyclizine shows no reports of levels entering breast milk and is unlikely to produce adverse effects if used short term 1
- First-generation antihistamines can cause sedation in infants and may potentially reduce milk supply
Recommendation: Chlorpheniramine can be used with caution. Monitor the infant closely for excessive drowsiness, irritability, or poor feeding. If sedation occurs, consider switching to a non-sedating antihistamine or discontinuing use.
Dextromethorphan (Cough Suppressant)
- Recent research (2022) shows that dextromethorphan and its active metabolite dextrorphan are extensively distributed into breast milk with M/P ratios of 1.0 and 1.6 respectively 4
- However, the relative infant dose (RID) was estimated to be <1%, which is well below the 10% safety threshold
- One case of erythematous rash in a nursing infant was reported, warranting caution 4
Recommendation: Dextromethorphan can be used during breastfeeding as the RID is minimal. Monitor the infant for skin rashes, sedation, or unusual behavior. If any adverse effects occur, discontinue immediately.
Dexamethasone Clarification
If "dexomethorphine" refers to dexamethasone (corticosteroid):
- No data are available on the transfer of dexamethasone into human milk, but other corticosteroids have been used extensively during breastfeeding with no evidence of any effects 1
Recommendation: Dexamethasone is compatible with breastfeeding.
Overall Clinical Approach
Monitor the infant for:
- Gastrointestinal symptoms: Diarrhea, loose stools (from cefixime)
- Sedation or drowsiness: Particularly from chlorpheniramine
- Skin reactions: Rash or erythema (from dextromethorphan)
- Feeding difficulties: Poor sucking, irritability
- Oral candidiasis: White patches in mouth (from antibiotic)
Key Pitfalls to Avoid:
- Do not automatically discontinue breastfeeding when these medications are prescribed
- Do not assume all cold/cough medications are unsafe—the evidence supports their use with monitoring
- Do not ignore infant sedation if it occurs—this requires immediate medication review
- Consider timing doses immediately after breastfeeding to minimize infant exposure at peak milk concentrations
Duration Considerations: The combination appears to be for an upper respiratory infection. Use the shortest effective duration (typically 5-7 days for the antibiotic, shorter for symptomatic medications). The short-term nature of this regimen further supports its safety profile during lactation.